$OMER
OMEROS CORP

2023 Q4 Form 10-Q Financial Statement

#000143774923031250 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.88M $16.42M
YoY Change -19.97% 34.63%
% of Gross Profit
Research & Development $28.89M $31.73M
YoY Change 8.82% -17.73%
% of Gross Profit
Depreciation & Amortization $205.0K $197.0K
YoY Change 25.77% -38.44%
% of Gross Profit
Operating Expenses $39.77M $48.15M
YoY Change -0.93% 24.85%
Operating Profit -$48.15M
YoY Change -5.15%
Interest Expense -$7.063M $7.916M
YoY Change -10.63% 60.5%
% of Operating Profit
Other Income/Expense, Net $3.429M $4.413M
YoY Change 72.05% 387.09%
Pretax Income -$39.29M -$51.66M
YoY Change -14.68% -5.72%
Income Tax
% Of Pretax Income
Net Earnings -$9.068M -$37.80M
YoY Change -107.04% 116.54%
Net Earnings / Revenue
Basic Earnings Per Share -$0.60
Diluted Earnings Per Share -$0.14 -$0.60
COMMON SHARES
Basic Shares Outstanding 62.87M 62.86M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $171.9M $310.3M
YoY Change -11.83% 40.44%
Cash & Equivalents $7.105M $30.64M
Short-Term Investments $164.8M $279.7M
Other Short-Term Assets $8.581M $4.922M
YoY Change 36.21% -17.73%
Inventory
Prepaid Expenses
Receivables $36.10M $35.89M
Other Receivables $1.372M $220.0K
Total Short-Term Assets $217.9M $351.3M
YoY Change -50.84% 21.76%
LONG-TERM ASSETS
Property, Plant & Equipment $1.950M $1.717M
YoY Change -91.61% -92.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.054M $1.054M
YoY Change 0.0% 0.0%
Total Long-Term Assets $160.4M $141.7M
YoY Change 8.55% -16.14%
TOTAL ASSETS
Total Short-Term Assets $217.9M $351.3M
Total Long-Term Assets $160.4M $141.7M
Total Assets $378.3M $493.1M
YoY Change -35.99% 7.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.712M $5.866M
YoY Change 28.77% -65.67%
Accrued Expenses $31.87M $34.86M
YoY Change 4.31% 93.49%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $8.576M $101.6M
YoY Change -91.06%
Total Short-Term Liabilities $53.32M $147.2M
YoY Change -60.91% 272.47%
LONG-TERM LIABILITIES
Long-Term Debt $329.7M $340.6M
YoY Change -4.84% -22.56%
Other Long-Term Liabilities $20.23M $19.25M
YoY Change -9.74% -21.54%
Total Long-Term Liabilities $349.9M $359.8M
YoY Change -5.14% -22.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $53.32M $147.2M
Total Long-Term Liabilities $349.9M $359.8M
Total Liabilities $403.3M $507.0M
YoY Change -20.19% 0.63%
SHAREHOLDERS EQUITY
Retained Earnings -$753.5M -$744.5M
YoY Change 18.53% -2.61%
Common Stock $728.5M $730.5M
YoY Change 0.99% 1.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$24.98M -$13.95M
YoY Change
Total Liabilities & Shareholders Equity $378.3M $493.1M
YoY Change -35.99% 7.76%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$9.068M -$37.80M
YoY Change -107.04% 116.54%
Depreciation, Depletion And Amortization $205.0K $197.0K
YoY Change 25.77% -38.44%
Cash From Operating Activities -$34.83M -$32.65M
YoY Change 37.2% 23.48%
INVESTING ACTIVITIES
Capital Expenditures $118.0K $33.00K
YoY Change 807.69% 1000.0%
Acquisitions
YoY Change
Other Investing Activities $116.4M $57.20M
YoY Change -207.27% 73.35%
Cash From Investing Activities $116.2M $57.17M
YoY Change -207.15% 73.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -105.0M -483.0K
YoY Change 16021.81% -100.39%
NET CHANGE
Cash From Operating Activities -34.83M -32.65M
Cash From Investing Activities 116.2M 57.17M
Cash From Financing Activities -105.0M -483.0K
Net Change In Cash -23.54M 24.04M
YoY Change -82.5% -81.71%
FREE CASH FLOW
Cash From Operating Activities -$34.83M -$32.65M
Capital Expenditures $118.0K $33.00K
Free Cash Flow -$34.94M -$32.68M
YoY Change 37.6% 23.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62865491
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62865491
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62828765
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62828765
omer Contract Royalty Asset Noncash Interest
ContractRoyaltyAssetNoncashInterest
11484000 usd
us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
-14924000 usd
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
7280000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
839595000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
427000 usd
CY2021Q4 omer Milestone Period
MilestonePeriod
P4Y
CY2023Q3 omer Number Of Options To Extend Lease Term
NumberOfOptionsToExtendLeaseTerm
2 pure
CY2023Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34475
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-1663741
dei Entity Address Address Line1
EntityAddressAddressLine1
201 Elliott Avenue West
dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98119
dei City Area Code
CityAreaCode
206
dei Local Phone Number
LocalPhoneNumber
676-5000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
OMER
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62865491
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30640000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11009000 usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
279670000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
183909000 usd
CY2023Q3 omer Royalty Receivable Current
RoyaltyReceivableCurrent
29228000 usd
CY2022Q4 omer Royalty Receivable Current
RoyaltyReceivableCurrent
28797000 usd
CY2023Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
6878000 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
213221000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4922000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6300000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
351338000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
443236000 usd
CY2023Q3 omer Royalty Receivable Noncurrent
RoyaltyReceivableNoncurrent
119502000 usd
CY2022Q4 omer Royalty Receivable Noncurrent
RoyaltyReceivableNoncurrent
123425000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19460000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21762000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1717000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1492000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1054000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1054000 usd
CY2023Q3 us-gaap Assets
Assets
493071000 usd
CY2022Q4 us-gaap Assets
Assets
590969000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5866000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5989000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
34859000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30551000 usd
CY2023Q3 us-gaap Senior Notes Current
SeniorNotesCurrent
94909000 usd
CY2022Q4 us-gaap Senior Notes Current
SeniorNotesCurrent
94381000 usd
CY2023Q3 omer Royalty Obligation Current
RoyaltyObligationCurrent
6654000 usd
CY2022Q4 omer Royalty Obligation Current
RoyaltyObligationCurrent
1152000 usd
CY2023Q3 omer Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
4888000 usd
CY2022Q4 omer Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
4310000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
147176000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
136383000 usd
CY2023Q3 us-gaap Senior Long Term Notes
SeniorLongTermNotes
221828000 usd
CY2022Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
220906000 usd
CY2023Q3 omer Royalty Liabilities Noncurrent
RoyaltyLiabilitiesNoncurrent
118770000 usd
CY2022Q4 omer Royalty Liabilities Noncurrent
RoyaltyLiabilitiesNoncurrent
125126000 usd
CY2023Q3 omer Lease Liabilities Noncurrent
LeaseLiabilitiesNoncurrent
19249000 usd
CY2022Q4 omer Lease Liabilities Noncurrent
LeaseLiabilitiesNoncurrent
22426000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
0 usd
CY2022Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
444000 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
628000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
628000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
729882000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
720773000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-744462000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-635717000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-13952000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
85684000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
493071000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
590969000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31731000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38568000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
85980000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
86172000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16422000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12198000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
38785000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
37079000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
48153000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
50766000 usd
us-gaap Costs And Expenses
CostsAndExpenses
124765000 usd
us-gaap Costs And Expenses
CostsAndExpenses
123251000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-48153000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-50766000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-124765000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-123251000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
7916000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
4932000 usd
us-gaap Interest Expense
InterestExpense
23781000 usd
us-gaap Interest Expense
InterestExpense
14799000 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
4413000 usd
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
906000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
12913000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
2069000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-51656000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-54792000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-135633000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-135981000 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
13906000 usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
37336000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
26888000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
54665000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-37750000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-17456000 usd
us-gaap Net Income Loss
NetIncomeLoss
-108745000 usd
us-gaap Net Income Loss
NetIncomeLoss
-81316000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.82
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.87
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.16
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.17
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.22
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.59
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.43
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.87
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.6
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.3
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62856721
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62730015
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62840990
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62728276
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
85684000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2953000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-33701000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
54936000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
97000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2771000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-37294000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
20510000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
53000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3235000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-37750000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-13952000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
23780000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
414000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3892000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-33011000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-4925000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3072000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-30849000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-32702000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3844000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-17456000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-46314000 usd
us-gaap Net Income Loss
NetIncomeLoss
-108745000 usd
us-gaap Net Income Loss
NetIncomeLoss
-81316000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
8959000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
10808000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1450000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1361000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
715000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
789000 usd
omer Contract Royalty Asset Noncash Interest
ContractRoyaltyAssetNoncashInterest
13739000 usd
us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
-40631000 usd
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-0 usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-0 usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
454000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-206343000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-24301000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-876000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1769000 usd
omer Increase Decrease In Contract Royalty Asset
IncreaseDecreaseInContractRoyaltyAsset
-29900000 usd
omer Increase Decrease In Contract Royalty Asset
IncreaseDecreaseInContractRoyaltyAsset
-47555000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3741000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-11544000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
109551000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-61101000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
103573000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
751114000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
84600000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
308000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
100000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88789000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19073000 usd
omer Proceeds From Liability For Future Royalties Received
ProceedsFromLiabilityForFutureRoyaltiesReceived
0 usd
omer Proceeds From Liability For Future Royalties Received
ProceedsFromLiabilityForFutureRoyaltiesReceived
125000000 usd
omer Principal Payments On Royalty Obligations
PrincipalPaymentsOnRoyaltyObligations
854000 usd
omer Principal Payments On Royalty Obligations
PrincipalPaymentsOnRoyaltyObligations
-0 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
515000 usd
omer Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
150000 usd
omer Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
414000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1131000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
124899000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19631000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
44725000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11009000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
100808000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30640000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
145533000 usd
us-gaap Interest Paid Net
InterestPaidNet
23801000 usd
us-gaap Interest Paid Net
InterestPaidNet
13437000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
632000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
806000 usd
CY2021Q4 omer Milestone Payment If Achieved Under Asset Purchase Agreement
MilestonePaymentIfAchievedUnderAssetPurchaseAgreement
200000000 usd
CY2022Q4 omer Milestone Payment Receivable
MilestonePaymentReceivable
200000000 usd
CY2021Q4 omer Percentage Of Royalty Receivable On Sale Of Product Rights
PercentageOfRoyaltyReceivableOnSaleOfProductRights
0.50 pure
CY2022Q4 omer Percentage Of Royalty Receivable On Sale Of Product Rights
PercentageOfRoyaltyReceivableOnSaleOfProductRights
0.30 pure
CY2023Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
310300000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-37800000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
109600000 usd
CY2023Q1 omer Cash Proceeds From Milestone Payment
CashProceedsFromMilestonePayment
200000000 usd
CY2023Q3 omer Equity Offering Facility Maximum Aggregate Offering Amount
EquityOfferingFacilityMaximumAggregateOfferingAmount
150000000 usd
CY2021Q4 omer Percentage Of Royalty Receivable On Sale Of Product Rights
PercentageOfRoyaltyReceivableOnSaleOfProductRights
0.50 pure
CY2022Q4 omer Percentage Of Royalty Receivable On Sale Of Product Rights
PercentageOfRoyaltyReceivableOnSaleOfProductRights
0.30 pure
CY2022Q4 omer Milestone Payment Receivable
MilestonePaymentReceivable
200000000 usd
CY2022Q4 omer Percentage Of Royalty Receivable On Sale Of Product Rights
PercentageOfRoyaltyReceivableOnSaleOfProductRights
0.30 pure
CY2023Q1 omer Percentage Of Interest Earned On Outstanding Contract Royalty Asset
PercentageOfInterestEarnedOnOutstandingContractRoyaltyAsset
0.11 pure
CY2022Q4 omer Milestone Payment If Achieved Under Asset Purchase Agreement
MilestonePaymentIfAchievedUnderAssetPurchaseAgreement
200000000 usd
CY2021Q4 omer Percentage Of Royalty Receivable On Sale Of Product Rights
PercentageOfRoyaltyReceivableOnSaleOfProductRights
0.50 pure
CY2022Q4 omer Percentage Of Royalty Receivable On Sale Of Product Rights
PercentageOfRoyaltyReceivableOnSaleOfProductRights
0.30 pure
CY2023Q1 us-gaap Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
200000000 usd
CY2021Q4 omer Percentage Of Reduction In Royalty Receivable Upon Breach Of Agreement Term
PercentageOfReductionInRoyaltyReceivableUponBreachOfAgreementTerm
0.10 pure
CY2023Q1 omer Milestone Payment If Achieved Under Asset Purchase Agreement
MilestonePaymentIfAchievedUnderAssetPurchaseAgreement
200000000 usd
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17218446
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17333039
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17221390
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17321993
CY2023Q3 omer Royalty Receivable Current
RoyaltyReceivableCurrent
29228000 usd
CY2022Q4 omer Royalty Receivable Current
RoyaltyReceivableCurrent
28797000 usd
CY2023Q3 omer Royalty Receivable Noncurrent
RoyaltyReceivableNoncurrent
119502000 usd
CY2022Q4 omer Royalty Receivable Noncurrent
RoyaltyReceivableNoncurrent
123425000 usd
CY2023Q3 omer Contract Royalty Asset
ContractRoyaltyAsset
148730000 usd
CY2022Q4 omer Contract Royalty Asset
ContractRoyaltyAsset
152222000 usd
CY2023Q3 omer Royalty Receivable
RoyaltyReceivable
6658000 usd
CY2022Q4 omer Royalty Receivable
RoyaltyReceivable
12966000 usd
CY2023Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
220000 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
255000 usd
CY2023Q3 omer Milestone Payment Receivable
MilestonePaymentReceivable
0 usd
CY2022Q4 omer Milestone Payment Receivable
MilestonePaymentReceivable
200000000 usd
CY2023Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
6878000 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
213221000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11753000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11040000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10036000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9548000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1717000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1492000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
200000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
300000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
700000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
800000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12556000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6665000 usd
CY2023Q3 omer Accrued Clinical Trial Costs
AccruedClinicalTrialCosts
9351000 usd
CY2022Q4 omer Accrued Clinical Trial Costs
AccruedClinicalTrialCosts
5536000 usd
CY2023Q3 omer Accrued Contract Research Costs
AccruedContractResearchCosts
4158000 usd
CY2022Q4 omer Accrued Contract Research Costs
AccruedContractResearchCosts
3209000 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
3703000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
5172000 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3005000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4425000 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1228000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4871000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
858000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
673000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
34859000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30551000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
4000000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
400000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
11700000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
600000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
279670000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
2000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
279672000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale And Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
280724000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
2000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale And Held To Maturity Fair Value
DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue
280726000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
183909000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
22000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
183931000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale And Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
184963000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
22000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale And Held To Maturity Fair Value
DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue
184985000 usd
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
320030000 usd
CY2023Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3293000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
316737000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
320030000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
4743000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
315287000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
95000000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
225030000 usd
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
320030000 usd
CY2023Q3 omer Royalty Obligation Principal Payments Due Remainder Of Fiscal Year
RoyaltyObligationPrincipalPaymentsDueRemainderOfFiscalYear
298000 usd
CY2023Q3 omer Royalty Obligation Interest Payments Due Remainder Of Fiscal Year
RoyaltyObligationInterestPaymentsDueRemainderOfFiscalYear
2952000 usd
CY2023Q3 omer Royalty Obligation Payments Due Remainder Of Fiscal Year
RoyaltyObligationPaymentsDueRemainderOfFiscalYear
3250000 usd
CY2023Q3 omer Royalty Obligation Principal Payments Due Next Twelve Months
RoyaltyObligationPrincipalPaymentsDueNextTwelveMonths
8576000 usd
CY2023Q3 omer Royalty Obligation Interest Payments Due Next Twelve Months
RoyaltyObligationInterestPaymentsDueNextTwelveMonths
11424000 usd
CY2023Q3 omer Royalty Obligation Payments Due Next Twelve Months
RoyaltyObligationPaymentsDueNextTwelveMonths
20000000 usd
CY2023Q3 omer Royalty Obligation Principal Payments Due Year Two
RoyaltyObligationPrincipalPaymentsDueYearTwo
14641000 usd
CY2023Q3 omer Royalty Obligation Interest Payments Due Year Two
RoyaltyObligationInterestPaymentsDueYearTwo
10359000 usd
CY2023Q3 omer Royalty Obligation Payments Due Year Two
RoyaltyObligationPaymentsDueYearTwo
25000000 usd
CY2023Q3 omer Royalty Obligation Principal Payments Due Year Three
RoyaltyObligationPrincipalPaymentsDueYearThree
16081000 usd
CY2023Q3 omer Royalty Obligation Interest Payments Due Year Three
RoyaltyObligationInterestPaymentsDueYearThree
8919000 usd
CY2023Q3 omer Royalty Obligation Payments Due Year Three
RoyaltyObligationPaymentsDueYearThree
25000000 usd
CY2023Q3 omer Royalty Obligation Principal Payments Due Year Four
RoyaltyObligationPrincipalPaymentsDueYearFour
17664000 usd
CY2023Q3 omer Royalty Obligation Interest Payments Due Year Four
RoyaltyObligationInterestPaymentsDueYearFour
7336000 usd
CY2023Q3 omer Royalty Obligation Payments Due Year Four
RoyaltyObligationPaymentsDueYearFour
25000000 usd
CY2023Q3 omer Royalty Obligation Principal Payments Due After Year Five
RoyaltyObligationPrincipalPaymentsDueAfterYearFive
68164000 usd
CY2023Q3 omer Royalty Obligation Interest Payments Due After Year Five
RoyaltyObligationInterestPaymentsDueAfterYearFive
10586000 usd
CY2023Q3 omer Royalty Obligation Payments Due After Year Five
RoyaltyObligationPaymentsDueAfterYearFive
78750000 usd
CY2023Q3 omer Royalty Obligation Principal Payments Due
RoyaltyObligationPrincipalPaymentsDue
125424000 usd
CY2023Q3 omer Royalty Obligation Interest Payments Due
RoyaltyObligationInterestPaymentsDue
51576000 usd
CY2023Q3 omer Royalty Obligation Payments Due
RoyaltyObligationPaymentsDue
177000000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1100000 usd
CY2022Q1 omer Decrease In Right Of Use Asset Due To Early Operating Lease Termination
DecreaseInRightOfUseAssetDueToEarlyOperatingLeaseTermination
4700000 usd
CY2022Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
500000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1603000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1659000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
4852000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
4529000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
140000 usd
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
250000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
529000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
570000 usd
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
29000 usd
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
32000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
121000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
123000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
807000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
813000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
2354000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
2395000 usd
CY2023Q3 us-gaap Sublease Income
SubleaseIncome
375000 usd
CY2022Q3 us-gaap Sublease Income
SubleaseIncome
432000 usd
us-gaap Sublease Income
SubleaseIncome
1125000 usd
us-gaap Sublease Income
SubleaseIncome
1377000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
2204000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
2322000 usd
us-gaap Lease Cost
LeaseCost
6731000 usd
us-gaap Lease Cost
LeaseCost
6240000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
5356000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
5312000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
499000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
598000 usd
CY2023Q3 omer Longterm Purchase Commitment Termination Fee
LongtermPurchaseCommitmentTerminationFee
27400000 usd
CY2021Q1 omer Equity Offering Facility Maximum Aggregate Offering Amount
EquityOfferingFacilityMaximumAggregateOfferingAmount
150000000 usd
CY2023Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
200000
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
23
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3235000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3844000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8959000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10808000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13872973
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2908200
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.13
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
36726
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.1
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1439517
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
10.12
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15304930
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.62
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M18D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
80000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
14760623
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
9.78
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y2M12D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
77000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
10169314
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.75
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M18D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
44000 usd
CY2023Q3 omer Common Stock Shares Outstanding Above Period End Closing Price
CommonStockSharesOutstandingAbovePeriodEndClosingPrice
15200000
CY2023Q3 us-gaap Share Price
SharePrice
2.92

Files In Submission

Name View Source Status
0001437749-23-031250-index-headers.html Edgar Link pending
0001437749-23-031250-index.html Edgar Link pending
0001437749-23-031250.txt Edgar Link pending
0001437749-23-031250-xbrl.zip Edgar Link pending
ex_567193.htm Edgar Link pending
ex_567194.htm Edgar Link pending
ex_567195.htm Edgar Link pending
ex_567196.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
omer-20230930.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
omer-20230930_def.xml Edgar Link unprocessable
omer-20230930_lab.xml Edgar Link unprocessable
omer-20230930_pre.xml Edgar Link unprocessable
omer-20230930_cal.xml Edgar Link unprocessable
omer20230930_10q_htm.xml Edgar Link completed
omer20230930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending